Hani Salehi-Had, MD
Retina Specialist · Huntington Beach, CANPI 1306909403
Payments from drug & device makers
Across 1,316 payments — averaging $9241.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$9.1M
- Regeneron$1.8M
- Apellis Pharmaceuticals, Inc.$250K
- Kyowa Kirin, Inc.$239K
- Eyepoint US, Inc.$237K
- Boehringer Ingelheim International GmbH$157K
- plus $401K from 24 others
Across 3 payments — averaging $514.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$1K
- Regeneron$432
- Novo Nordisk$48
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 56 | $9,072,844 |
| Regeneron | 854 | $1,804,490 |
| Apellis Pharmaceuticals, Inc. | 39 | $250,183 |
| Kyowa Kirin, Inc. | 65 | $238,556 |
| Eyepoint US, Inc. | 6 | $237,330 |
| Boehringer Ingelheim International GmbH | 109 | $157,318 |
| Ocular Therapeutix, Inc. | 7 | $103,694 |
| AbbVie(2 entities) | 41 | $90,975 |
| Hexal AG | 12 | $83,143 |
| Janssen Research & Development, LLC | 10 | $58,531 |
| Boehringer Ingelheim | 9 | $42,423 |
| Genentech, Inc. | 8 | $11,650 |
| Novo Nordisk AS | 3 | $5,500 |
| Alimera Sciences, Inc. | 4 | $1,612 |
| Regeneron Healthcare Solutions, Inc. | 19 | $903 |
| Alcon | 8 | $745 |
| Genentech USA, Inc. | 14 | $542 |
| Sun Pharmaceutical Industries Inc. | 9 | $446 |
| Astellas Pharma US Inc | 22 | $411 |
| Astellas Pharma Global Development | 5 | $220 |
| Harrow Eye, LLC | 2 | $152 |
| Bausch & Lomb Americas Inc. | 4 | $100 |
| Coherus Oncology, Inc. | 2 | $66 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $34 |
| Dompe US, Inc. | 1 | $34 |
| Amgen | 1 | $23 |
| Lumibird Medical Inc. | 1 | $23 |
| Spark Therapeutics, Inc. | 1 | $21 |
| Biogen | 1 | $20 |
How this compares
$12,162,027 in reported general payments places this provider in the 95th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Huntington Beach
- Dante PieramiciSanta Barbara$15.1M
- Margaret ChangSacramento$13.2M
- Payam AminiPasadena$9.9M
- Joel PearlmanSacramento$8.3M
- Dilsher DhootSanta Barbara$8.2M
- Ashkan PirouzFullerton$6.9M
- Roger GoldbergWalnut Creek$5M
- Sean AdreanFullerton$2.9M
- Nathan SteinleSanta Barbara$2.6M
- Darius MoshfeghiPalo Alto$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.